Immunome, Inc. (IMNM) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$10,211
Total Return
2.11%
CAGR
0.42%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.54% |
| Median | -0.71% |
| Best | +138.01% |
| Worst | -54.25% |
| % of Windows Positive | 47.9% |
1-Year (252 Trading Days)
| Average | +54.59% |
| Median | +39.37% |
| Best | +531.41% |
| Worst | -85.12% |
| % of Windows Positive | 60.9% |
3-Year (756 Trading Days)
| Average | +147.83% |
| Median | +106.55% |
| Best | +825.34% |
| Worst | -50.55% |
| % of Windows Positive | 70.3% |
Risk Metrics
| Maximum Drawdown | -92.04% |
| Average Drawdown | -56.94% |
| Drawdown Duration | 1175 Trading Days (Unrecovered) |
| Sortino Ratio | 0.70 |
| Calmar Ratio | 0.00 |
| CVaR (5%) | -11.33% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -7.77% (-17.47% ann.) | $777.47 | $0.00 | $0.00 | $0.00 |
| 2025 | +102.26% | +$10225.99 | $0.00 | $0.00 | $0.00 |
| 2024 | -0.75% | $74.77 | $0.00 | $0.00 | $0.00 |
| 2023 | +384.16% | +$38416.37 | $0.00 | $0.00 | $0.00 |
| 2022 | -82.95% | $8294.76 | $0.00 | $0.00 | $0.00 |
| 2021 | +33.88% | +$3388.43 | $0.00 | $0.00 | $0.00 |
| 2020 partial | -28.03% (-73.68% ann.) | $2802.97 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | October 2, 2020 – November 6, 2020 | -13.75% | -78.65% | $1375.46 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +67.54% | +63.17% | +$6754.37 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -78.10% | -80.06% | $7810.03 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +275.61% | +104.21% | +$27560.93 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +27.81% | +15.47% | +$2780.65 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.